Kristina Masson
Co-Founder, Executive VP of Business Operations, Site Head, Treasurer & DirectorMs. Kristina Masson, Ph. D., M. B.A., is Director of Aqilion AB. Ms. Masson is the Co-Founder, Treasurer and Director of Acrivon Therapeutics, Inc. and served as its Global Head of Operations was secretary. She serves as a Director at Acrivon Therapeutics, Inc. since March 2018. She has been an Executive Vice President of Business Operations at Acrivon Therapeutics Inc since August 2022 and serves as its Site Head of Acrivon AB located in Medicon Village, Sweden. She served as Senior Vice President of Operations for Acrivon Therapeutics Inc since March 2018 until August 2022. She serves as President and Site Head of research subsidiary Acrivon AB located in Medicon Village, Sweden. She has established all infrastructure, Heads all operations and runs the phospho-proteomic discovery hub and early drug programs for the company’s proprietary AP3 platform. In 2016, she founded and operated OncoSignature AB, a small biotech company focused on identifying predictive biomarkers for clinical-stage cancer therapeutics for US companies. She was Principal Scientist at Merrimack Pharmaceuticals, Cambridge, MA where she co-led, managed and participated in cross-functional teams in both preclinical and clinical-stage therapeutic antibody programs, designing projects to identify predictive biomarkers, combination strategies and resistance mechanisms. Before joining Merrimack Pharmaceuticals, She was a Post-Doctoral Fellow in the Golub lab at the Broad Institute of MIT and Harvard, developing assays for novel therapeutics and automated high-throughput drug screening approaches centered around synthetic lethality in cancer. She received an MSc and a Ph. D. from Lund University and conducted her Post-Doctoral Fellowship at the Broad Institute of MIT and Harvard.
Positions
- Company NameAcrivon Therapeutics, Inc.Stock CodeACRVPositionCo-Founder, Executive VP of Business Operations, Site Head, Treasurer & DirectorColleagues
- PBPeter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
- EJEric J. DevroeChief Operating Officer
- ADAdam D. LevyCFO & Principal Financial Officer
- KPKatharine PetersonVice President of Finance & Accounting
- JVJesper V. OlsenAcademic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board
- MJMichael John TomsicekIndependent Director
- CMCharles M. BaumIndependent Director
